Robeco Institutional Asset Management
RCUS icon

Robeco Institutional Asset Management’s Arcus Biosciences RCUS Stock Holding History

Robeco Institutional Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,143
Closed -$23.2K – 1052
2023
Q2 		$23.2K Sell
1,143
-54,366
-98% -$1.04M ﹤0.01% 1021
2023
Q1 		$1.01M Buy
55,509
+9,516
+21% +$182K ﹤0.01% 774
2022
Q4 		$951K Buy
45,993
+15,890
+53% +$437K ﹤0.01% 784
2022
Q3 		$788K Buy
30,103
+9,428
+46% +$249K ﹤0.01% 717
2022
Q2 		$524K Buy
+20,675
New +$506K ﹤0.01% 764

Other funds holding RCUS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return